Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW
9,090.00
+310.00 (3.53%)
Apr 10, 2026, 3:30 PM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2013 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '13 Dec 31, 2013 |
|---|
Pharmaceutical Research and Development Projects, Etc. | | | 8.93B | 14.36B | 10.57B | 18.75B | 9.31B | | | |
Pharmaceutical Research and Development Projects, Etc. Growth | | | -37.83% | 35.90% | -43.65% | 101.53% | - | | | |
Consolidation Adjustments | | | -4.73B | -11.56B | -8.25B | -14.51B | -4.85B | | | |
| | | 4.20B | 2.80B | 2.32B | 4.25B | 4.45B | | | |
| | | 50.08% | 20.87% | -45.48% | -4.63% | - | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2013 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '13 Dec 31, 2013 |
|---|
| | | 3.36B | 2.39B | 1.95B | 3.83B | 4.03B | | | |
| | | 40.81% | 22.64% | -49.10% | -5.04% | -21.60% | | | |
| | | 157.16M | 231.41M | 59.74M | 28.24M | 275.67M | | | |
| | | -32.09% | 287.35% | 111.57% | -89.76% | 93.47% | | | |
| | | 681.52M | 179.94M | 309.12M | 450.48M | 150.23M | | | |
| | | 278.75% | -41.79% | -31.38% | 199.86% | - | | | |
| | | 4.20B | 2.80B | 2.32B | 4.30B | 4.45B | | | |
| | | 50.08% | 20.87% | -46.19% | -3.37% | -15.65% | | | |
Source: S&P Global Market Intelligence.
